UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD)

CUSIP: 917488108

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 6 signals
Share change
-9,726
SEC-reported price per share
$100.00
Number of holders
78
Value change
-$912,880
Number of buys
30
Number of sells
34
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
3,188,980

Security key

917488108

Report period

Q4 2021

Institutions

78

Top holders

10

Ownership snapshot

Top reported holders of UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
22 Nov 2021
13F 3/4/5 Highest disclosed value: $46,129,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $46.13M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
FMR LLC $46.13M
PRICE T ROWE ASSOCIATES INC /MD/ $26.12M
RENAISSANCE TECHNOLOGIES LLC $21.36M
BlackRock Finance, Inc. $20.08M
VANGUARD GROUP INC $20.02M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
—
denominator unverified
$46,129,000
496,863 shares
— 30 Sep 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$26,124,000
281,385 shares
— 30 Sep 2021
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$21,356,000
230,035 shares
— 30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$20,078,000
216,259 shares
— 30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$20,025,000
215,693 shares
— 30 Sep 2021
Kevin L. Cornwell
3/4/5
Chairman, CEO, Secretary, Director
—
denominator unverified
$17,774,794
188,472 shares
— 22 Nov 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
78
Shares
2,603,370
Rows available
78
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q2 2026 Across Filers

Q2 2026 holders
114
Q4 2021 holders
78
Holder diff
-36
Investor Q2 2026 Shares Q4 2021 Shares Share Diff Share Chg % Q2 2026 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .